Loading viewer...
report
Format: PDF report
This report presents primary results from a Phase 1 study of Antolimab, an investigational antibody for treating chronic gastrointestinal symptoms linked to mast cells.
presentation
report
TriNet Group
report
Trek Bicycle Corporation
report
Sika
report
Entergy Corporation